Christopher L. Wallace

532 total citations
12 papers, 406 citations indexed

About

Christopher L. Wallace is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Pharmacology. According to data from OpenAlex, Christopher L. Wallace has authored 12 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 5 papers in Toxicology and 3 papers in Pharmacology. Recurrent topics in Christopher L. Wallace's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Forensic Toxicology and Drug Analysis (5 papers) and Cannabis and Cannabinoid Research (2 papers). Christopher L. Wallace is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Forensic Toxicology and Drug Analysis (5 papers) and Cannabis and Cannabinoid Research (2 papers). Christopher L. Wallace collaborates with scholars based in United States. Christopher L. Wallace's co-authors include John D. Roache, Roberta Kahn, Ahmed Elkashef, Nora Chiang, Richard De La Garza, Thomas F. Newton, Nassima Ait‐Daoud, Lynda Wells, Bankole A. Johnson and Timothy Fong and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Christopher L. Wallace

12 papers receiving 394 citations

Peers

Christopher L. Wallace
Dan Creson United States
Kishorchandra Gonsai United States
Rajkumar J. Sevak United States
Faiq A. Hameedi United States
Chih-Ken Chen Taiwan
Atapol Sughondhabirom Thailand
Phillip Saccone United States
Takeo Ishiguro Japan
Jennifer E. Learn United States
Tomohiro Miyakawa Japan
Dan Creson United States
Christopher L. Wallace
Citations per year, relative to Christopher L. Wallace Christopher L. Wallace (= 1×) peers Dan Creson

Countries citing papers authored by Christopher L. Wallace

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Wallace more than expected).

Fields of papers citing papers by Christopher L. Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Wallace. The network helps show where Christopher L. Wallace may publish in the future.

Co-authorship network of co-authors of Christopher L. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Wallace. A scholar is included among the top collaborators of Christopher L. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Wallace. Christopher L. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Haas, Nathan L., et al.. (2019). Epinephrine Administered for Anaphylaxis Unmasking a Type 1 Brugada Pattern on Electrocardiogram. Journal of Emergency Medicine. 56(4). 444–447. 2 indexed citations
2.
Roache, John D., Roberta Kahn, Thomas F. Newton, et al.. (2011). A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug and Alcohol Dependence. 119(1-2). 37–45. 13 indexed citations
3.
Kahn, Roberta, Kousick Biswas, Steven Shoptaw, et al.. (2009). Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug and Alcohol Dependence. 103(1-2). 59–64. 56 indexed citations
4.
Carter, Lawrence P., et al.. (2007). Relative Abuse Liability of Indiplon and Triazolam in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects. Journal of Pharmacology and Experimental Therapeutics. 322(2). 749–759. 11 indexed citations
5.
Johnson, Bankole A., Lynda Wells, John D. Roache, et al.. (2006). Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(2). 455–461. 8 indexed citations
6.
Johnson, Bankole A., John D. Roache, Nassima Ait‐Daoud, et al.. (2006). Effects of acute topiramate dosing on methamphetamine-induced subjective mood. The International Journal of Neuropsychopharmacology. 10(1). 85–85. 40 indexed citations
7.
Johnson, Bankole A., John D. Roache, Nassima Ait‐Daoud, et al.. (2006). Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(1). 123–130. 33 indexed citations
8.
Newton, Thomas F., John D. Roache, Richard De La Garza, et al.. (2005). Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology. 182(3). 426–435. 49 indexed citations
9.
Johnson, Bankole A., John D. Roache, Nassima Ait‐Daoud, et al.. (2005). Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals. The International Journal of Neuropsychopharmacology. 8(4). 549–549. 17 indexed citations
10.
Newton, Thomas F., John D. Roache, Richard De La Garza, et al.. (2005). Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving. Neuropsychopharmacology. 31(7). 1537–1544. 131 indexed citations
11.
Johnson, Bankole A., John D. Roache, Nassima Ait‐Daoud, et al.. (2005). Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. The International Journal of Neuropsychopharmacology. 8(2). 203–213. 18 indexed citations
12.
Johnson, Bankole A., John D. Roache, Nassima Ait‐Daoud, et al.. (2004). Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Psychopharmacology. 178(2-3). 296–302. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan Creson Breakdown of academic impact, for papers by Kishorchandra Gonsai Breakdown of academic impact, for papers by Rajkumar J. Sevak Breakdown of academic impact, for papers by Faiq A. Hameedi Breakdown of academic impact, for papers by Chih-Ken Chen Breakdown of academic impact, for papers by Atapol Sughondhabirom Breakdown of academic impact, for papers by Phillip Saccone Breakdown of academic impact, for papers by Takeo Ishiguro Breakdown of academic impact, for papers by Jennifer E. Learn Breakdown of academic impact, for papers by Tomohiro Miyakawa
Rankless by CCL
2026